The Asia Pacific Nephrology and Urology Devices Market would witness market growth of 7.0% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 35,161.8 thousand units, showcasing a growth of 6.4% (2019-2022).
It is expected that the market will experience a surge in the purchase of nephrology and urology devices, propelled by the growing need for minimally invasive procedures made possible by recent technological developments. Stents for the ureter, catheters, guidewires, and renal dilators are among the apparatuses that are manufactured utilizing cutting-edge substances like silicone, polyurethanes/polycarbonates, and nitinol. Carbothane exhibits chemical resistance, including that of iodine, hydrogen peroxide, and alcohol, extending its operational lifespan. Carbothane, utilized in the MAHURKAR Chronic Carbothane catheter developed by Medtronic, provides superior kink resistance, facilitates insertion, and permits high flow rates with minimal pressure in the arteries and veins.
A substantial senior population, which is exceptionally prone to numerous diseases such as kidney and urinary disorders, is anticipated to propel the market. The advancing age of an individual is widely recognized as a substantial risk factor in the onset of numerous medical conditions. The immune system is compromised with advancing age, rendering individuals more susceptible to ailments including urinary retention, diabetes, prostate cancer, and renal complications.
The rising healthcare expenditure in Asia Pacific, driven by economic growth and increased government spending on healthcare, supports investments in medical devices. Several Asian Pacific governments are implementing initiatives to improve healthcare infrastructure and services. Nephrology and urology devices play a crucial role in these preventive measures. Due to the aforementioned factors the market growth will drive in this region.
The China market dominated the Asia Pacific Nephrology and Urology Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $669 million by 2030. The Japan market is registering a CAGR of 6.2% during (2023 - 2030). Additionally, The India market would experience a CAGR of 7.7% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Based on Application, the market is segmented into Kidney Diseases, Bladder Disorders, Urolithiasis, Urological Cancer & BPH, and Others. Based on Product, the market is segmented into Urology Guidewires, Stone Basket, Renal Dilators, Mesh & Inserts, Ureteral Catheters, Urinary Stents, PCN Catheters, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
It is expected that the market will experience a surge in the purchase of nephrology and urology devices, propelled by the growing need for minimally invasive procedures made possible by recent technological developments. Stents for the ureter, catheters, guidewires, and renal dilators are among the apparatuses that are manufactured utilizing cutting-edge substances like silicone, polyurethanes/polycarbonates, and nitinol. Carbothane exhibits chemical resistance, including that of iodine, hydrogen peroxide, and alcohol, extending its operational lifespan. Carbothane, utilized in the MAHURKAR Chronic Carbothane catheter developed by Medtronic, provides superior kink resistance, facilitates insertion, and permits high flow rates with minimal pressure in the arteries and veins.
A substantial senior population, which is exceptionally prone to numerous diseases such as kidney and urinary disorders, is anticipated to propel the market. The advancing age of an individual is widely recognized as a substantial risk factor in the onset of numerous medical conditions. The immune system is compromised with advancing age, rendering individuals more susceptible to ailments including urinary retention, diabetes, prostate cancer, and renal complications.
The rising healthcare expenditure in Asia Pacific, driven by economic growth and increased government spending on healthcare, supports investments in medical devices. Several Asian Pacific governments are implementing initiatives to improve healthcare infrastructure and services. Nephrology and urology devices play a crucial role in these preventive measures. Due to the aforementioned factors the market growth will drive in this region.
The China market dominated the Asia Pacific Nephrology and Urology Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $669 million by 2030. The Japan market is registering a CAGR of 6.2% during (2023 - 2030). Additionally, The India market would experience a CAGR of 7.7% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Based on Application, the market is segmented into Kidney Diseases, Bladder Disorders, Urolithiasis, Urological Cancer & BPH, and Others. Based on Product, the market is segmented into Urology Guidewires, Stone Basket, Renal Dilators, Mesh & Inserts, Ureteral Catheters, Urinary Stents, PCN Catheters, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
Scope of the Study
Market Segments Covered in the Report:
By End-use (Volume, Thousand Units, USD Billion, 2019-2030)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
- Kidney Diseases
- Bladder Disorders
- Urolithiasis
- Urological Cancer & BPH
- Others
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
- Urology Guidewires
- Stone Basket
- Renal Dilators
- Mesh & Inserts
- Ureteral Catheters
- Urinary Stents
- PCN Catheters
- Others
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Hollister, Inc.
- Medtronic PLC
- Coloplast Group
- Boston Scientific Corporation
- ConvaTec Group PLC
- Baxter International, Inc.
- Asahi Kasei Corporation
- Cook Medical, Inc. (Cook Group)
- Terumo Corporation
- Teleflex Incorporated
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Nephrology And Urology Devices Market by End-use
Chapter 5. Asia Pacific Nephrology And Urology Devices Market by Application
Chapter 6. Asia Pacific Nephrology And Urology Devices Market by Product
Chapter 7. Asia Pacific Nephrology And Urology Devices Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Hollister, Inc.
- Medtronic PLC
- Coloplast Group
- Boston Scientific Corporation
- ConvaTec Group PLC
- Baxter International, Inc.
- Asahi Kasei Corporation
- Cook Medical, Inc. (Cook Group)
- Terumo Corporation
- Teleflex Incorporated
Methodology
LOADING...
